ReviewFrontiers in microbiology2017
Overview on the Biochemical Potential of Filamentous Fungi to Degrade Pharmaceutical Compounds.
Review in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed.
- Helicoverpa armigera (Lepidoptera, Noctuidae) as a reservoir of potential polystyrene-degrading fungi.BMC microbiology · 2026Article
- Prevalence and Associated Risk Factors of Hypertension Among Middle-Aged and Older Tribal Adults-Evidence from Longitudinal Ageing Study in India (LASI).Journal of racial and ethnic health disparities · 2026Article
- Exploring Fungal Biodegradation Pathways of 2,4-D: Enzymatic Mechanisms, Synergistic Actions, and Environmental Applications.ACS omega · 2025Review
- Biotransformation of Antibiotics byAntibiotics (Basel, Switzerland) · 2025Article
- Bioremediation of methotrexate by Pleurotus ostreatus pellets: effects on morphology and biotransformation insights.Biodegradation · 2025Article
- Production of protein-rich fungal biomass from pistachio dehulling waste using edible Neurospora intermedia.Scientific reports · 2025Article
- Strategies for the Remediation of Micro- and Nanoplastics from Contaminated Food and Water: Advancements and Challenges.Journal of xenobiotics · 2025Review
- Assessing Recent Technologies for Addressing Microplastic Pollution and Pushing the Case of Bioremediation as an Attractive Approach.Recent advances in food, nutrition & agriculture · 2025Review
- Microbial degradation of microplastics: Effectiveness, challenges, and sustainable solutions.Current research in microbial sciences · 2025Review
- Environmental Implication of Herbicide Use.Molecules (Basel, Switzerland) · 2024Review
- Biodegradation of low-density polyethylene by mixed fungi composed of Alternaria sp. and Trametes sp. isolated from landfill sites.BMC microbiology · 2024Article
- Bioremediation of petroleum refinery wastewater by fungal stains isolated from the fishing harbour of Bizerte (Mediterranean Sea).Biodegradation · 2024Article
- Article
- "You Are What You Eat": How Fungal Adaptation Can Be Leveraged toward Myco-Material Properties.Global challenges (Hoboken, NJ) · 2024Article
- Pharmaceutically active micropollutants: origin, hazards and removal.Frontiers in microbiology · 2024Review
- Impact of veterinary pharmaceuticals on environment and their mitigation through microbial bioremediation.Frontiers in microbiology · 2024Review
- Microplastics and environmental effects: investigating the effects of microplastics on aquatic habitats and their impact on human health.Frontiers in public health · 2024Review
- Investigation of the Persistence, Toxicological Effects, and Ecological Issues of S-Triazine Herbicides and Their Biodegradation Using Emerging Technologies: A Review.Microorganisms · 2023Review
- Secondary Metabolites, Biological Activities, and Industrial and Biotechnological Importance ofMarine drugs · 2023Review
- Fungal biodegradation of chlorinated herbicides: an overview with an emphasis on 2,4-D in Argentina.Biodegradation · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceuticals represent an immense business with increased demand due to intensive livestock raising and an aging human population, which guarantee the quality of human life and well-being. However, the development of removal technologies for these compounds is not keeping pace with the swift increase in their use. Pharmaceuticals constitute a potential risk group of multiclass chemicals of increasing concern since they are extremely frequent in all environments and have started to exhibit negative effects on micro- and macro-fauna as well as on human health. In this context, fungi are known to be extremely diverse and poorly studied microorganisms despite being well suited for bioremediation processes, taking into account their metabolic and physiological characteristics for the transformation of even highly toxic xenobiotic compounds. Increasing studies indicate that fungi can transform many structures of pharmaceutical compounds, including anti-inflammatories, β-blockers, and antibiotics. This is possible due to different mechanisms in combination with the extracellular and intracellular enzymes, which have broad of biotechnological applications. Thus, fungi and their enzymes could represent a promising tool to deal with this environmental problem. Here, we review the studies performed on pharmaceutical compounds biodegradation by the great diversity of these eukaryotes. We examine the state of the art of the current application of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.